Season 4, Episode Special - Promoting Liver Health: an urgent call for action at WHO
On 22 May 2023, policymakers, thought leaders, Permanent Mission Representatives to the UN, WHO staff, and people affected by liver disease will gather at the EASL Office in Geneva for the invitation-only event on the side-lines of the 76th World Health Assembly*: “Together for Better Liver Health: Mobilising Action for Fatty Liver Disease”. The aim of the event is to raise awareness on the need for action, and to call for a coordinated response to combat the global public health threat represented by fatty liver disease.
Fatty liver disease is the most prevalent liver disease in history, affecting over one in three adults globally and 10% of children. If left unchecked, it can progress to cirrhosis and liver cancer. Despite its prevalence, fatty liver disease remains largely unknown, and its burden is expected to grow further in the years ahead.
Following the event, an EASL Studio special episode “Promoting Liver Health: an urgent call for action at WHO” will air at 19:30 – 20:00 pm CET on 22 May.
This is your chance to join the high-level discussion in a thought-provoking and informative format and hear the priorities and challenges from key stakeholders in the field.
The episode will showcase the collective effort of global stakeholders who stand united to advocate that fatty liver diseases are included in national and global policies. Our moderator, EASL Vice-Secretary Prof. Aleksander Krag, will be joined by distinguished faculty members representing organisations from around the world.
Don’t miss this opportunity to learn about the strategies being put in place to promote liver health and the urgent need for coordinated approaches. Participate in this call for action to address fatty liver disease as a critical step toward a healthier future for all.
The EASL Studio special episode can be accessed online from wherever in the world you are located –we look forward to having you among our audience!
*The World Health Assembly is held annually and is an occasion for all WHO member delegations to discuss and make strides on global health issues. The EASL event builds upon WHA76 agenda item 11.2 which includes discussions on policy options and cost-effective interventions for the prevention and control of noncommunicable disease (NCDs). By raising the profile of fatty liver disease, the EASL’s event on the side-lines of the WHA and the publicly accessible EASL Studio special episode can help to catalyse action and improve liver health outcomes worldwide.
Faculty: Prof. Aleksander Krag (Moderator), Prof. Ajay Duseja (Faculty), Prof. Manal El-Sayed (Faculty), Mr. Marko Korenjak (Faculty), Prof. Mario Pessoa (Faculty), Prof. Mary E. Rinella (Faculty)
This EASL Studio has been sponsored by Boehringer Ingelheim and Novo Nordisk. The sponsors have had no editorial control over the content featured.
